Within the TCGA Breast Invasive Carcinoma PanCancer Atlas dataset (n = 996) mutations of METTL3, METTL14 and CBLL1 were uncommon, with amplifications being the most common genetic alteration (Supplementary Fig. 1A). This evidence concerns the gene CBLL1 and invasive breast carcinoma.